As noted in the recent MDL transfer order, plaintiffs in Bard inferior vena cava (IVC) filter lawsuits are planning to seek more information about safety violations identified at two Bard facilities. Bard IVC filter plaintiffs hope the streamlined multidistrict litigation discovery process will aid in them getting information about these violations.
Bard is the country’s foremost producer of retrievable IVC filters—small, cage-like devices that are implanted into the vena cava to catch blood clots before they reach ...
continue reading...
The U.S. Judicial Panel on Multidistrict Litigation decided on earlier this month to centralize 22 Bard inferior vena cava (IVC) filter lawsuits before the U.S. District Court for the District of Arizona. Lopez McHugh co-founder 
The U.S. Judicial Panel on Multidistrict Litigation has ordered the transfer of all federal lawsuits filed over allegedly defective IVC filters made by medical device manufacturer C.R. Bard, Inc. to the District of Arizona following the appearance at a July 30 hearing of lead IVC filter attorney 
A recent letter from the U.S. Food and Drug Administration (FDA) reveals that IVC maker C. R. Bard committed several quality system violations at its facilities in Queensbury, New York, and Tempe, Arizona. According to the FDA, Bard failed to “establish and maintain procedures for receiving, reviewing, and evaluating complaints as required by [law].” The agency cites several instances in which Bard’s quality system did not ensure adequate evaluation ...
